# Progress in Glaucoma Management in the Era of Value-Based Healthcare

## TL;DR

This paper explores how value-based healthcare is changing glaucoma treatment by focusing on better outcomes and cost efficiency.

## Contribution

It introduces performance indicators to evaluate glaucoma management under the VBHC model.

## Key findings

- Minimally invasive glaucoma procedures are becoming popular alternatives to traditional surgeries.
- Early intervention is now more feasible due to safer treatment options.
- Cost-effectiveness of these new procedures remains an open question.

## Abstract

Medical care is increasingly evolving towards patient-centered medicine, which is at the heart of the value-based healthcare (VBHC) model. The VBHC model simultaneously prioritizes better health outcomes while optimizing costs. Its application therefore requires the use of quantitative indicators to assess the performance of healthcare systems. At the same time, in glaucoma, minimally invasive procedures are expanding therapeutic options, gaining popularity and establishing themselves as an attractive alternative to traditional, riskier glaucoma surgeries. These safer procedures are increasingly enabling early intervention in the care pathway of glaucoma patients. However, their cost-effectiveness remains to be determined. This work aims to analyze the impact of the current approach to glaucoma management through the VBHC model and to discuss performance indicators that allow for effective evaluation.